Sciele Pharma, Inc. (SCRX), a Shionogi & Co., Ltd. Company, to Acquire Addrenex Pharmaceuticals, a U.S. Specialty Pharmaceutical Company
11/16/2009 10:36:14 AM
More...
|
Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma
8/5/2009 9:31:00 AM
More...
|
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
5/13/2009 8:34:30 AM
More...
|
Sciele Pharma, Inc. (SCRX) and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD
4/23/2009 12:10:00 PM
More...
|
Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
4/23/2009 9:13:10 AM
More...
|
Sciele Pharma, Inc. (SCRX) Announces That Addrenex Pharmaceuticals Initiates Phase II Clinical Trial of ADX415 for the Treatment of Hypertension
10/23/2008 2:02:21 PM
More...
|
Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
10/23/2008 9:56:05 AM
More...
|
Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
9/11/2008 6:34:05 AM
More...
|
Sciele Pharma, Inc. (SCRX) and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD
9/10/2008 12:28:06 PM
More...
|
Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
8/20/2008 7:29:45 AM
More...
|
|